Hafrun Fridriksdottir

2017

In 2017, Hafrun Fridriksdottir earned a total compensation of $3.7M as Executive Vice President, Global Research and Development at Teva Pharmaceutical Industries.

Compensation breakdown

Bonus$900,000
Non-Equity Incentive Plan$535,000
Option Awards$500,047
Salary$696,346
Stock Awards$999,957
Other$77,492
Total$3,708,842

Fridriksdottir received $1M in stock awards, accounting for 27% of the total pay in 2017.

Fridriksdottir also received $900K in bonus, $535K in non-equity incentive plan, $500K in option awards, $696.3K in salary and $77.5K in other compensation.

Rankings

In 2017, Hafrun Fridriksdottir's compensation ranked 2,821st out of 14,666 executives tracked by ExecPay. In other words, Fridriksdottir earned more than 80.8% of executives.

ClassificationRankingPercentile
All
2,821
out of 14,666
81st
Division
Manufacturing
965
out of 5,772
83rd
Major group
Chemicals And Allied Products
256
out of 2,075
88th
Industry group
Drugs
195
out of 1,731
89th
Industry
Pharmaceutical Preparations
155
out of 1,333
88th
Source: SEC filing on April 25, 2018.

Fridriksdottir's colleagues

We found nine more compensation records of executives who worked with Hafrun Fridriksdottir at Teva Pharmaceutical Industries in 2017.

2017

Kåre Schultz

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Yitzhak Peterburg

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Rob Koremans

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Carlo de Notaristefani

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

2017

Michael Hayden

Teva Pharmaceutical Industries

Chief Scientific Officer

2017

Eyal Desheh

Teva Pharmaceutical Industries

Chief Financial Officer

2017

Erez Vigodman

Teva Pharmaceutical Industries

Chief Executive Officer

2017

Mark Sabag

Teva Pharmaceutical Industries

Executive Vice President, Global Human Resources

2017

Michael McClellan

Teva Pharmaceutical Industries

Chief Financial Officer

News

You may also like